120 related articles for article (PubMed ID: 32540820)
21. Monitoring serum cytokeratin 19 fragment 21-1 to determine the efficacy of docetaxel chemotherapy in advanced extramammary Paget's disease.
Onishi M; Maeda F; Akasaka T; Amano H
J Dermatol; 2019 Mar; 46(3):e83-e84. PubMed ID: 30194782
[No Abstract] [Full Text] [Related]
22. Complete response of extramammary Paget's disease with imiquimod and PDT: Report of two cases.
Apalla Z; Lallas A; Tsorova A; Nikolaidou C; Vakirlis E; Ioannides D; Sotiriou E
Photodermatol Photoimmunol Photomed; 2018 Jul; 34(4):273-275. PubMed ID: 29575126
[No Abstract] [Full Text] [Related]
23. Sequential use with imiquimod and surgery in extramammary Paget's disease.
Toledo F; Silvestre JF; Cuesta L; Ballester I; Latorre N; Monteagudo A
Dermatol Ther; 2012; 25(1):82-5. PubMed ID: 22591501
[TBL] [Abstract][Full Text] [Related]
24. Extramammary Paget's disease recurring on the skin of the lower abdomen and entire right leg two and half years after simple vulvectomy for minimally invasive Paget's disease of the vulva.
Piura B; Vardy D; Meirovitz M; Cohen Y; Yanai-Inbar I
Eur J Obstet Gynecol Reprod Biol; 1998 Feb; 76(2):217-20. PubMed ID: 9481578
[TBL] [Abstract][Full Text] [Related]
25. Unfavorable efficacy of pembrolizumab for advanced extramammary Paget's disease with high tumor mutation burden after failure of taxane-based regimens.
Koizumi S; Doi R; Aitake U; Lei X; Izumi T; Mori T; Shojiguchi N; Kawasaki T; Inozume T; Kishi A
J Dermatol; 2024 Jun; 51(6):e203-e204. PubMed ID: 38216840
[No Abstract] [Full Text] [Related]
26. Metastatic extramammary Paget's disease successfully controlled with tumour dormancy therapy using docetaxel.
Fujisawa Y; Umebayashi Y; Otsuka F
Br J Dermatol; 2006 Feb; 154(2):375-6. PubMed ID: 16433815
[No Abstract] [Full Text] [Related]
27. A multi-institution phase II study of docetaxel and S-1 in combination with trastuzumab for HER2-positive advanced gastric cancer (DASH study).
Kagawa S; Muraoka A; Kambara T; Nakayama H; Hamano R; Tanaka N; Noma K; Tanakaya K; Kishimoto H; Shigeyasu K; Kuroda S; Kikuchi S; Kuwada K; Nishizaki M; Shirakawa Y; Fujiwara T
Cancer Chemother Pharmacol; 2018 Feb; 81(2):387-392. PubMed ID: 29290024
[TBL] [Abstract][Full Text] [Related]
28. Usefulness of docetaxel as first-line chemotherapy for metastatic extramammary Paget's disease.
Yoshino K; Fujisawa Y; Kiyohara Y; Kadono T; Murata Y; Uhara H; Hatta N; Uchi H; Matsushita S; Takenouchi T; Hayashi T; Ohara K
J Dermatol; 2016 Jun; 43(6):633-7. PubMed ID: 26603144
[TBL] [Abstract][Full Text] [Related]
29. Double involvement of extramammary Paget's disease in the genitalia and axilla.
Inui S; Fukuhara S; Asada H; Tadokoro T; Yoshikawa K; Itami S
J Dermatol; 2000 Jun; 27(6):409-12. PubMed ID: 10920590
[TBL] [Abstract][Full Text] [Related]
30. Metastatic extramammary Paget's disease responding to weekly paclitaxel.
Phuoc V; Grothey A
BMJ Case Rep; 2015 Apr; 2015():. PubMed ID: 25903204
[TBL] [Abstract][Full Text] [Related]
31. Successful treatment of metastatic extramammary Paget's disease with pemetrexed monotherapy systemically and 5-fluorouracil topically.
Chen K; Liang H; Peng J; Zheng Y
Indian J Dermatol Venereol Leprol; 2019; 85(1):56-59. PubMed ID: 29536970
[TBL] [Abstract][Full Text] [Related]
32. Metastatic extramammary Paget's disease treated with paclitaxel and trastuzumab combination chemotherapy.
Takahagi S; Noda H; Kamegashira A; Madokoro N; Hori I; Shindo H; Mihara S; Hide M
J Dermatol; 2009 Aug; 36(8):457-61. PubMed ID: 19691751
[TBL] [Abstract][Full Text] [Related]
33. Novel ex vivo disease model for extramammary Paget's disease using the cancer tissue-originated spheroid method.
Arita T; Kondo J; Kaneko Y; Tsutsumi M; Kanemaru M; Matsui M; Arakawa Y; Katoh N; Inoue M; Asai J
J Dermatol Sci; 2020 Sep; 99(3):185-192. PubMed ID: 32800410
[TBL] [Abstract][Full Text] [Related]
34. Comparison of the biomarkers for targeted therapies in primary extra-mammary and mammary Paget's disease.
Gatalica Z; Vranic S; Krušlin B; Poorman K; Stafford P; Kacerovska D; Senarathne W; Florento E; Contreras E; Leary A; Choi A; In GK
Cancer Med; 2020 Feb; 9(4):1441-1450. PubMed ID: 31899853
[TBL] [Abstract][Full Text] [Related]
35. Dynamics of blood neutrophil-related indices during nivolumab treatment may be associated with response to salvage chemotherapy for non-small cell lung cancer: A hypothesis-generating study.
Soda H; Ogawara D; Fukuda Y; Tomono H; Okuno D; Koga S; Taniguchi H; Yoshida M; Harada T; Umemura A; Yamaguchi H; Mukae H
Thorac Cancer; 2019 Feb; 10(2):341-346. PubMed ID: 30582295
[TBL] [Abstract][Full Text] [Related]
36. Metastatic in-situ perianal Paget's disease.
Khoubehi B; Schofield A; Leslie M; Slevin ML; Talbot IC; Northover JM
J R Soc Med; 2001 Mar; 94(3):137-8. PubMed ID: 11285798
[No Abstract] [Full Text] [Related]
37. Usefulness of sentinel lymph node biopsy for the detection of metastasis in the early stage of extramammary Paget's disease.
Kusatake K; Harada Y; Mizumoto K; Kaneko S; Niihara H; Chinuki Y; Morita E
Eur J Dermatol; 2015 Apr; 25(2):156-61. PubMed ID: 26075323
[TBL] [Abstract][Full Text] [Related]
38. Successful human epidermal growth receptor 2-targeted therapy beyond disease progression for extramammary Paget's disease.
Watanabe S; Takeda M; Takahama T; Iwasa T; Tsurutani J; Tanizaki J; Shimizu T; Sakai K; Wada Y; Isogai N; Nishio K; Nakagawa K
Invest New Drugs; 2016 Jun; 34(3):394-6. PubMed ID: 26856856
[TBL] [Abstract][Full Text] [Related]
39. [Topical therapy of extramammary Paget's disease].
Arensmeier M; Theuring U; Franke I; Willgeroth C; Kühne KH
Hautarzt; 1994 Nov; 45(11):780-2. PubMed ID: 7822204
[TBL] [Abstract][Full Text] [Related]
40. A randomized phase II study of a combination of docetaxel and S-1 versus docetaxel monotherapy in patients with non-small cell lung cancer previously treated with platinum-based chemotherapy: results of Okayama Lung Cancer Study Group (OLCSG) Trial 0503.
Segawa Y; Kiura K; Hotta K; Takigawa N; Tabata M; Matsuo K; Yoshioka H; Hayashi H; Kawai H; Aoe K; Maeda T; Ueoka H; Tanimoto M
J Thorac Oncol; 2010 Sep; 5(9):1430-4. PubMed ID: 20651615
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
